Jazz Pharmaceuticals Faces Setback as PTSD Drug Fails Mid-Stage Trial

Jazz Pharmaceuticals Faces Setback as PTSD Drug Fails Mid-Stage Trial

Jazz Pharmaceuticals (JAZZ.O) encountered a setback as its investigational drug, JZP150, designed for the treatment of post-traumatic stress disorder (PTSD),…